David Bick, MD, presenting to sold-out crowd at ACMG.
Nearly a dozen faculty members and scientists from HudsonAlpha Institute for Biotechnology were selected to share their research findings in genomics and genetics at the American College of Medical Genetics and Genomics (ACMG) annual meeting in Charlotte, NC.
David Bick, MD, faculty investigator and chief medical genomics officer at HudsonAlpha, kicked off the Wednesday sessions with a special satellite symposium presentation exploring clinical utility of genomics.
His talk, “Performance of Whole Genome Sequencing versus Whole Exome Sequencing,” dug into data gleaned from many cases in which whole genome or whole exome (or both technologies) were utilized to attempt to solve clinical cases.
Based on that data, Bick asserts whole genome sequencing (WGS) is superior to whole exome sequencing (WES).
“Whole genome actually provides better exome data than simply sequencing an exome. WGS gives a higher diagnostic yield and in cases of urgency, should be a first line test. We have made many diagnoses using WGS where WES failed,” Bick said.
The opening reception for ACMG 2018 was held Wednesday evening.
Poster sessions featuring HudsonAlpha scientists will be held Thursday and Friday mornings.
